Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

'This is not science fiction,' say scientists pushing for 'neuro-rights'

Published 12/03/2020, 06:04 PM
Updated 12/03/2020, 07:05 PM

By Avi Asher-Schapiro

( Thomson Reuters (NYSE:TRI) Foundation) - Scientific advances from deep brain stimulation to wearable scanners are making manipulation of the human mind increasingly possible, creating a need for laws and protections to regulate use of the new tools, top neurologists said on Thursday.

A set of "neuro-rights" should be added to the Universal Declaration of Human Rights adopted by the United Nations, said Rafael Yuste, a neuroscience professor at New York's Columbia University and organizer of the Morningside Group of scientists and ethicists proposing such standards.

Five rights would guard the brain against abuse from new technologies - rights to identity, free will and mental privacy along with the right of equal access to brain augmentation advances and protection from algorithmic bias, the group says.

“If you can record and change neurons, you can in principle read and write the minds of people,” Yuste said during an online panel at the Web Summit, a global tech conference.

“This is not science fiction. We are doing this in lab animals successfully."

Neurotechnology has the potential to alter the mechanisms that make people human, so putting it in a "human rights framework” is appropriate, he added.

The U.N.'s declaration, which laid the groundwork for international human rights, was adopted after World War II in 1948.

A need for neuro-rights will grow as the developments become more popular and commercialized, the neurologists said.

Many of these technologies so far have applications in medicine, such as brain-computer interfaces helping patients move prosthetic limbs or communicate after a brain injury.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

But those neurotechnologies increasingly will be available outside of the medical context, said John Krakauer, a professor of neurology and neuroscience at Johns Hopkins University in Maryland.

“Deep down what people want is consumer technologies,” he said.

The U.S. Food and Drug Administration has approved deep brain stimulation procedures - implanting electrodes in the brain - to treat a range of disorders from Parkinson's disease to epilepsy.

Some private companies sell wearable devices to monitor brain activity that claim to be capable of tracking moods and emotions.

Krakauer compared the latest neurotechnologies to advances such as social media and mass advertising that can be utilized to alter people's preferences without their expressed consent.

“What's changed now is that the tech can get under the skull and get at our neurons,” he said.

Globally, a number of legal measures are aimed at these advances, including legislation in Chile that if passed would be the first law to establish neuro-rights for citizens.

In November, the Spanish government proposed new rules for regulating artificial intelligence that includes specific provisions for neuro-rights, Yuste said.

“This is the first time in history that humans can have access to the contents of people's minds,” he said.

“We have to think very careful about how we are going to bring this into society.”

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.